fore-8394
forebio therapeutics
['fore8394', 'fore bio']
fore biotherapeutics presents positive interim data from phase 1/2a trial evaluating fore8394 in patients with advanced tumors with activating braf alterations at esmo 2022 - neuro central via brainsights for ios 
Stay on top of the latest Brain & Neuroscience research & news from all the best sources delivered directly to your iPhone/iPad